SEMA3F Activators
SEMA3F Activators encompass a range of chemical compounds that indirectly facilitate the functional activity of SEMA3F through their influence on various cellular signaling pathways. For instance, Forskolin and Rolipram, by raising cAMP levels, activate PKA, which may phosphorylate proteins involved in the regulation of actin cytoskeleton dynamics, a process critical for SEMA3F-mediated cellular guidance. Similarly, the lipid signaling molecule Sphingosine-1-phosphate may modulate SEMA3F function in neuronal guidance and vascular stabilization by engaging G-protein-coupled receptors. Inhibition of the Rho-associated kinase (ROCK) by Y-27632 allows for reduced cytoskeletal tension, thus potentiating SEMA3F's role in guiding cellular migration, while PI3K inhibitors like LY294002 and MEK inhibitors such as PD98059 and U0126 can modulate intracellular kinase pathways, shifting signaling equilibria in favor of SEMA.
SEMA3F Activators encompass a range of chemical compounds that indirectly facilitate the functional activity of SEMA3F through their influence on various cellular signaling pathways. For instance, Forskolin and Rolipram, by raising cAMP levels, activate PKA, which may phosphorylate proteins involved in the regulation of actin cytoskeleton dynamics, a process critical for SEMA3F-mediated cellular guidance. Similarly, the lipid signaling molecule Sphingosine-1-phosphate may modulate SEMA3F function in neuronal guidance and vascular stabilization by engaging G-protein-coupled receptors. Inhibition of the Rho-associated kinase (ROCK) by Y-27632 allows for reduced cytoskeletal tension, thus potentiating SEMA3F's role in guiding cellular migration, while PI3K inhibitors like LY294002 and MEK inhibitors such as PD98059 and U0126 can modulate intracellular kinase pathways, shifting signaling equilibria in favor of SEMA
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, which can activate protein kinase A (PKA). PKA phosphorylation can lead to changes in cytoskeletal dynamics and cellular migration, processes where SEMA3F is implicated as a guidance cue. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates G-protein-coupled receptors, potentially influencing SEMA3F signaling in neuronal guidance and vascular stabilization. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels which can indirectly enhance SEMA3F signaling through PKA activation. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin inhibits myosin II ATPase activity, which may enhance SEMA3F signaling by reducing contractile forces opposing the guidance cues that SEMA3F provides. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a myosin light chain kinase inhibitor that can reduce cell contraction and thus may indirectly enhance SEMA3F's role in cell guidance and migration by altering cellular tension. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, which could modulate SEMA3F signaling involved in neuronal growth cone activity and cell migration by altering calcium-dependent signaling pathways. | ||||||